Human TNF-alpha Recombinant Protein, Pep… and 5 more items

The University of Nebraska Medical Center, a state agency in Nebraska, awarded a purchase order (PO #4800177036) to Life Technologies Corporation, headquartered in Pittsburgh, Pennsylvania, on February 5, 2026. The contract, valued at $1,552.75, encompasses the procurement of recombinant proteins and laboratory reagents for delivery to the UNMC Shipping and Receiving department located at 601 South Saddle Creek Road, Omaha, Nebraska, with final unloading at Grace Bybee DRC1 8062. The period of performance extends from the award date of February 5, 2026, through the requested delivery date of February 16, 2026.

The contract deliverables consist of six line items categorized as recombinant protein products and laboratory extraction and inhibition reagents. The protein components include four recombinant cytokine products: Human TNF-alpha (Tumor Necrosis Factor-alpha), Mouse TNF-alpha, Human IL-1 beta (Interleukin-1 beta), and Mouse IL-1 beta, each priced at $224.00 per unit. Supporting laboratory reagents include two units of RIPA (Radioimmunoprecipitation Assay) Lysis and Extraction Buffer at $206.61 per unit and one unit of Halt Protease and Phosphatase Inhibitor at $243.53. Payment terms are established at Net 30 with Free on Board destination, freight prepaid, and vendor acceptance is required within ten days of the order date.